Treatment of primary central nervous system lymphoma

被引：0
作者：
Meltem Ekenel
Lisa M. DeAngelis
机构：
[1] Memorial Sloan-Kettering Cancer Center,Department of Neurology
来源：
Current Neurology and Neuroscience Reports | 2007年 / 7卷
关键词：
Overall Survival; Clin Oncol; Radiat Oncol Biol Phys; Autologous Stem Cell Transplantation; Busulfan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Primary central nervous system lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin’s lymphoma that is typically confined to brain, eyes, and cerebrospinal fluid without evidence of systemic spread. The prognosis of patients with PCNSL has improved during the past decade with the introduction of high-dose methotrexate with or without whole brain radiotherapy. However, despite recent progress, results following treatment are durable in few patients, and therapy can be associated with late neurotoxicity. PCNSL is an uncommon tumor, and no phase III trial has been completed so far, leaving many questions about its optimum first-line and salvage treatments unanswered. This review summarizes the literature regarding the treatment of PCNSL in immuno-competent patients.
引用
收藏
页码：191 / 199
页数：8
相关论文
共 147 条
[1]  
Olson J.E.(2002)The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis Cancer 95 1504-1510
[2]  
Janney C.A.(2005)Trends in survival from primary central nervous system lymphoma, 1975–1999 Cancer 104 2466-2472
[3]  
Rao R.D.(2000)Treatment for primary CNS lymphoma: the next step J Clin Oncol 18 3144-3150
[4]  
Panageas K.S.(1992)Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 83-15 Int J Radiat Oncol Biol Phys 23 9-17
[5]  
Elkin E.B.(2005)Prognostic factors in primary central nervous system lymphomas Hematol Oncol Clin North Am 19 629-649
[6]  
DeAngelis L.M.(2006)Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model J Clin Oncol 24 1-8
[7]  
Abrey L.E.(2005)Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases Eur J Surg Oncol 31 100-105
[8]  
Yahalom J.(1999)Glucocorticoid treatment of primary CNS lymphoma J Neuro-oncol 43 237-239
[9]  
DeAngelis L.M.(1997)Glucocorticoid induced long term remission in primary cerebral lymphoma: case report and review of literature J Neuro-oncol 32 63-69
[10]  
Nelson D.F.(2006)Whole-brain radiotherapy and high dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-75-51 Int J Radiat Oncol Biol Phys 65 1429-1439
12345678910